Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

The Creative Team Member: A Study of the Influence of AI Integration Timing on Brainstorming and Ideation

11 luglio 2026 aggiornato da: Mohit Bhandari, McMaster University

The Effect of Artificial Intelligence Integration Timing on Group Brainstorming and Ideation in Undergraduate Students: A Randomized Controlled Trial

This study aims to examine how the timing of artificial intelligence (AI) integration during group brainstorming activities affects the creativity and ideation of participants. Undergraduate student participants will be randomly allocated into teams of four to complete a structured 12-minute brainstorming task. The study utilizes a three-group experimental design to compare three conditions: no AI access, AI access from the outset of the session, and AI access introduced halfway through the session. The standardized generative AI tool used is ChatGPT Pro. The creative output produced by each group will be evaluated by a panel of independent expert judges using the Consensual Assessment Technique (CAT).

Panoramica dello studio

Descrizione dettagliata

Artificial intelligence (AI) tools are increasingly used in academic and professional environments, yet little is known about how the timing of AI's introduction during a collaborative brainstorming process shapes the creativity of the ideas produced. While recent literature suggests that human-AI collaboration can increase the likelihood of successful idea generation when AI is present throughout an entire session, the specific effect of integration timing remains a gap in the literature. This study aims to provide early data on whether AI functions more effectively as an early collaborator, a later resource, or whether its absence supports more creative thinking.

The study recruits undergraduate students enrolled in a summer research program, who are then randomly assigned to teams of four using a digital randomizer. Over the course of nine sessions, these teams participate in structured, 12-minute collaborative brainstorming tasks focused on designing strategies to address common university student challenges. To mitigate the influence of individual baseline characteristics on the group output, participants are re-randomized into new teams for each separate session.

To standardize the technological intervention and eliminate technical confounders, the study utilizes ChatGPT Pro (GPT-4o architecture) on pre-set devices. At the conclusion of the timed task, a designated team scribe submits the group's collaboratively generated idea list and their selected best idea via a secure, digital case report form.

Following data collection, all session outputs are immediately de-identified and assigned neutral identifiers. A panel of independent expert judges, blinded to the condition assignments, evaluate the output of each group.

Tipo di studio

Interventistico

Iscrizione (Stimato)

16

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Backup dei contatti dello studio

Luoghi di studio

    • Ontario
      • Hamilton, Ontario, Canada, L8S 4L8
        • McMaster University
        • Contatto:
        • Contatto:
        • Sub-investigatore:
          • Kaya Bhandari
        • Sub-investigatore:
          • Alexandra Leone, BSc
        • Investigatore principale:
          • Mohit Bhandari, MD, PhD, FRCSC

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Bambino
  • Adulto
  • Adulto più anziano

Accetta volontari sani

Sì

Descrizione

Inclusion Criteria:

  • Enrolled as a student in the designated summer research program
  • Able to provide voluntary informed consent
  • Proficient in reading and communicating in English (required to engage with the scenarios and the artificial intelligence tool)

Exclusion Criteria:

-Not enrolled as an undergraduate student

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Altro
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Nessun intervento: No Artificial Intelligence Tools (Control)
Across nine separate sessions, teams of four participants will complete all nine distinct student-struggle scenarios (one scenario per 12-minute session). In each session, participants engage in a structured collaborative brainstorming task entirely without access to artificial intelligence tools for the full 12 minutes. At the conclusion of each session, the team must evaluate their generated list and select their single best idea to solve that specific scenario.
Sperimentale: Artificial Intelligence First (Early Integration)
Across nine separate sessions, teams of four participants will complete all nine distinct student-struggle scenarios (one scenario per 12-minute session). In each session, at minute 0, participants input the scenario prompt into ChatGPT Pro (GPT-4o architecture). The team receives a single initial output of ideas and does not engage in further back-and-forth dialogue with the tool. Participants use this initial artificial intelligence response as a baseline to continue human brainstorming and ideation for the remainder of the 12 minutes, ultimately selecting and submitting their single best idea for that specific scenario.
The introduction of ChatGPT Pro (GPT-4o architecture) at the beginning (minute 0) of a 12-minute group brainstorming session. A single prompt containing the scenario is submitted to generate an initial set of ideas, with no further back-and-forth dialogue permitted. This single artificial intelligence output serves as the baseline for the team's subsequent human ideation.
Sperimentale: Artificial Intelligence Last (Late Integration)
Across nine separate sessions, teams of four participants will complete all nine distinct student-struggle scenarios (one scenario per 12-minute session). In each session, participants brainstorm independently without technology for the first 6 minutes. At minute 6, the team inputs the scenario prompt along with their already-generated human ideas into ChatGPT Pro (GPT-4o architecture). Receiving a single output with no further back-and-forth dialogue, the team uses the artificial intelligence response to continue ideating for the final 6 minutes, ultimately selecting and submitting their single best idea for that specific scenario.
The introduction of ChatGPT Pro (GPT-4o architecture) at the midpoint (minute 6) of a 12-minute group brainstorming session. A single prompt containing both the scenario and the team's already-generated human ideas is submitted, with no further back-and-forth dialogue permitted. This single artificial intelligence output is used to guide the team's human ideation for the remaining 6 minutes.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Creativity Score of the Selected Best Idea
Lasso di tempo: Evaluated cross-sectionally upon the conclusion of each 12-minute session, across the 9 study sessions.
The primary outcome is the mean expert creativity rating assigned to each team's top idea, across each of the 9 sessions, as assessed by independent judges using the Consensual Assessment Technique (CAT). Higher average scores denote a more creative output, while lower scores denote a less creative output.
Evaluated cross-sectionally upon the conclusion of each 12-minute session, across the 9 study sessions.

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Overall Creativity Score of Full Idea List
Lasso di tempo: Evaluated cross-sectionally upon the conclusion of each 12-minute session, across the 9 study sessions.
The collective creative quality of the entire list of ideas generated by the team during the session, evaluated by independent expert judges using the Consensual Assessment Technique (CAT).
Evaluated cross-sectionally upon the conclusion of each 12-minute session, across the 9 study sessions.
Number of Ideas Generated During the 12-Minute Session
Lasso di tempo: Evaluated cross-sectionally upon the conclusion of each 12-minute session, across the 9 study sessions.
The total number of ideas generated (fluency) will be reported with the explicit methodological limitation that AI generation speed inherently outpaces human typing speed. Fluency will be analysed purely observationally, as the 12-minute constraint does not control for the mechanical advantage of the AI tool.
Evaluated cross-sectionally upon the conclusion of each 12-minute session, across the 9 study sessions.
Qualitative Resemblance of the Team's Output to Typical AI-Generated Responses
Lasso di tempo: Evaluated cross-sectionally upon the conclusion of each 12-minute session, across the 9 study sessions.
This will be subjectively assessed by the expert judges on a 1-5 scale (anchored from 'strongly AI-typical' to 'strongly human'), independent of the CAT creativity evaluation.
Evaluated cross-sectionally upon the conclusion of each 12-minute session, across the 9 study sessions.

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Investigatore principale: Mohit Bhandari, MD, PhD, FRCSC, McMaster University

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Pubblicazioni generali

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

20 luglio 2026

Completamento primario (Stimato)

15 agosto 2026

Completamento dello studio (Stimato)

15 settembre 2026

Date di iscrizione allo studio

Primo inviato

5 luglio 2026

Primo inviato che soddisfa i criteri di controllo qualità

5 luglio 2026

Primo Inserito (Effettivo)

9 luglio 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

14 luglio 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

11 luglio 2026

Ultimo verificato

1 luglio 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Descrizione del piano IPD

Individual participant data (IPD) will not be shared publicly due to an elevated risk of deductive re-identification. While numeric outcomes could be anonymized, the primary data consists of raw qualitative text (transcribed group brainstorming ideas and solutions) generated by a highly specific, geographically localized cohort of undergraduate students enrolled in the 2026 summer research program. Because the 2026 cohort size is small and the context is unique, sharing raw textual transcripts poses a risk of accidentally exposing the identities of the participants through specific phrasing, examples, or contextual clues, despite de-identification efforts. Therefore, to ensure participant confidentiality in accordance with institutional ethics guidelines, the raw data will remain confidential within the primary research team.

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi